2011 Acquisition Pricing Study 
Xconomy
JANUARY 11, 2019
[ Editor’s note: Ben Fidler and Sarah de Crescenzo coauthored this report.] It is here, and then it is gone. But by the time everyone staggers to the airport or back home to sleep in their own beds, the annual few days of the J.P.
Xconomy
JULY 29, 2016
But the company said this week that sales of Sovaldi and Harvoni, which share a common ingredient, sofosbuvir, have slowed with fewer patients starting on the drugs and prices undercut by fierce competition from AbbVie and Merck. The study is one of several Celgene is running to try to expand the use of its blockbuster blood cancer drug.
SoCal CTO
JANUARY 5, 2011
Will Price , October 11, 2010 Georgians Should Vote No - Force of Good: a blog by Lance Weatherby , October 28, 2010 Free Software for Managing a Lean Startup - Platforms and Networks , January 17, 2010 Purpose Driven Life - Journey of a Serial Entrepreneur , July 26, 2010 Two Decade-Defining Acquisitions?
Expert insights. Personalized for you.
97 
Let's personalize your content